ProfileJobs

Apollo Endosurgery

Healthmedical devices
Apollo Endosurgery was founded upon the initial work of the Apollo Group, an international think tank of world-renowned gastroenterologists and surgeons from five leading universities (Mayo Clinic, Johns Hopkins, Medical University of South Carolina, University of Texas Medical Branch-Galveston and Chinese University-Hong Kong.) Disappointed with the pace of innovation in therapeutic flexible endoscopy, the Group assembled in 1998 (Timeline) with the goal to advance the new discipline; their specific focus was the use of long, flexible instruments deployed through a natural orifice in order to diagnose and potentially treat gastrointestinal disorders.
Revenue(Q1, 2017)
$14.6 M
Company Growth (employees)
Type
Private
HQ
Austin, US
Founded
2006
Size (employees)
233 (est)+6%
Website
apolloendo.com
Apollo Endosurgery was founded in 2006 and is headquartered in Austin, US

Apollo Endosurgery Office Locations

Apollo Endosurgery has an office in Austin
Austin, US (HQ)
300 1120 S Capital of Texas Hwy

Apollo Endosurgery Data and Metrics

Summary Metrics

Founding Date

2006

Total Funding

$289.8 m

Latest funding size

$22 m

Time since last funding

almost 2 years

Investors

East West Bank, Oxford Finance Corporation, MidCap Financial, Athyrium Capital Management, HIG Capital, PTV Healthcare Capital, UT Horizon Fund
Apollo Endosurgery's latest funding round in November 2015 was reported to be $22 m. In total, Apollo Endosurgery has raised $289.8 m

Apollo Endosurgery Financial Metrics

Apollo Endosurgery's revenue was reported to be $14.6 m in Q1, 2017
USD

Revenue (Q1, 2017)

14.6 m

Gross profit (Q1, 2017)

9.5 m

Gross profit margin (Q1, 2017), %

65%

Net income (Q1, 2017)

(8.2 m)

EBIT (Q1, 2017)

(6.8 m)

Cash (31-Mar-2017)

8.3 m
USDFY, 2016

Revenue

64.9 m

Cost of goods sold

25.3 m

Gross profit

39.6 m

Gross profit Margin, %

61%
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

1.3 m1.1 m783.9 k747.6 k61.3 k9.6 k9.2 k23.8 k14.6 m

Cost of goods sold

5.1 m

Gross profit

9.5 m

Gross profit Margin, %

65%
show all
USDFY, 2016

Cash

19.1 m

Accounts Receivable

10.5 m

Inventories

12.2 m

Current Assets

43.6 m
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

14.3 m20.5 m12.7 m11.9 m11.6 m7 m4.7 m3.3 m8.3 m

Accounts Receivable

1.3 m2.1 m1.4 m731.9 k56 k9.6 k9.2 k24.9 k

Inventories

11.7 m

Current Assets

16 m24.2 m14.5 m12.9 m11.8 m7.3 m5.3 m4 m32.1 m
show all
USDFY, 2016

Net Income

(41.2 m)

Depreciation and Amortization

7.2 m

Accounts Receivable

(426 k)

Inventories

(3.1 m)
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(3.7 m)(3.2 m)(2.8 m)(2.6 m)(2.2 m)(1.9 m)(2.7 m)(3.7 m)(8.2 m)

Depreciation and Amortization

1.8 m

Accounts Receivable

1.3 m2.1 m1.4 m731.9 k56 k9.6 k9.2 k24.9 k

Accounts Payable

2.5 m2.6 m2 m1.7 m1.2 m431.1 k462.7 k894.6 k6.4 m
show all
USDY, 2017

Revenue/Employee

77.9 k

Financial Leverage

2.6 x
Show all financial metrics

Market Position of Apollo Endosurgery

Competitors

K2M Group Holdings
Health - Public
Bruker Corporation
Health - Public
Smith & Nephew
Health - Public
Medequip
Health - Private
Compare competitors

Traffic Overview of Apollo Endosurgery

Apollo Endosurgery Online and Social Media Presence

Apollo Endosurgery Company Life and Culture

You may also be interested in